Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics

Journal of Alzheimer's Disease

Volumn 58, Issue 2, 2017, Pages 355-359

  Yilmaz, Ali ^a   Geddes, Tim ^a   Han, Beomsoo ^b   Bahado Singh, Ray O ^a   Wilson, George D ^a   Imam, Khaled ^a   Maddens, Michael ^a   Graham, Stewart F ^c  

^a Beaumont Research Institute   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

1H NMR; Alzheimer's disease; metabolomics; mild cognitive impairment

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; METABOLITE; METABOLOMICS; MILD COGNITIVE IMPAIRMENT; PILOT STUDY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SALIVA; AGED; COGNITIVE DEFECT; FEMALE; MALE; MENTAL HEALTH; METABOLISM; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITIVE DYSFUNCTION; EARLY DIAGNOSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MENTAL STATUS SCHEDULE; METABOLOMICS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; ROC CURVE; SALIVA;

EID: 85019215792     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-161226     Document Type: Article

References (24)

1. Monge-Argiles JA, Munoz-Ruiz C, Pampliega-Perez A, Gomez-Lopez MJ, Sanchez-Paya J, Rodriguez Borja E, Ruiz-Vegara M, Montoya-Gutierrez FJ, Leiva-Santana C (2011) Biomarkers of Alzheimer's disease in the cerebrospinal fluid of Spanish patients with mild cognitive impairment. Neurochem Res 36, 986-993.
2. Holscher C (2005) Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies. Rev Neurosci 16, 181-212.
3. Belbin O, Brown K, Shi H, Medway C, Abrahams R, Passmore P, Mann D, Smith AD, Holmes C, McGuiness B, Craig D, Warden D, Heun R, Kölsch H, Love S, Kalsheker N, Williams J, Owen MJ, Carrasquillo M, Younkin S, Morgan K, Kehoe PG (2011) A multi-centre study of ACE and the risk of late-onset Alzheimer's disease. J Alzheimers Dis 24, 587-597.
4. Burns A, Zaudig M (2002) Mild cognitive impairment in older people. Lancet 360, 1963-1965.
5. Mitchell AJ, Shiri-Feshki M (2009) Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 119, 252-265.
6. Geslani DM, Tierney MC, Herrmann N, Szalai JP (2005) Mild cognitive impairment: An operational definition and its conversion rate to Alzheimer's disease. Dement Geriatr Cogn Disord 19, 383-389.
7. Hölscher C, Li L (2010) New roles for insulin-like hormones in neuronal signalling and protection: New hopes for novel treatments of Alzheimer's disease? Neurobiol Aging 31, 1495-1502.
8. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2, 2692-2703.
9. Graham SF, Chevallier OP, Roberts D, Holscher C, Elliott CT, Green BD (2013) Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease. Anal Chem 85, 1803-1811.
10. Inoue K, Tsutsui H, Akatsu H, Hashizume Y, Matsukawa N, Yamamoto T, Toyo'oka T (2013) Metabolic profiling of Alzheimer's disease brains. Sci Rep 3, 2364.
11. Kaddurah-Daouk R, Zhu H, Sharma S, BogdanovM, Rozen SG, Matson W, Oki NO, Motsinger-Reif AA, Churchill E, Lei Z, Appleby D, Kling MA, Trojanowski JQ, Doraiswamy PM, Arnold SE (2013) Alterations in metabolic pathways and networks in Alzheimer's disease. Transl Psychiatry 3, e244.
12. Motsinger-Reif AA, Zhu H, Kling MA, MatsonW, Sharma S, Fiehn O, Reif DM, Appleby DH, Doraiswamy PM, Trojanowski JQ, Kaddurah-Daouk R, Arnold SE (2013) Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging. Acta Neuropathol Commun 1, 1-9.
13. Han X, Rozen S, Boyle SH, Hellegers C, Cheng H, Burke JR, Welsh-Bohmer KA, Doraiswamy PM, Kaddurah-Daouk R (2011) Metabolomics in early Alzheimer's disease: Identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One 6, e21643.
14. Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD, Rich SA, Berlau DJ, Peltz CB, Tan MT, Kawas CH, Federoff HJ (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20, 415-418.
15. Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C (2009) Understanding the human salivary metabolome. NMR Biomed 22, 577-584.
16. Loo JA, Yan W, Ramachandran P, Wong DT (2010) Comparative human salivary and plasma proteomes. J Dent Res 89, 1016-1023.
17. Spielmann N, Wong DT (2011) Saliva: Diagnostics and therapeutic perspectives. Oral Dis 17, 345-354.
18. Figueira J, Jonsson P, Nordin Adolfsson A, Adolfsson R, Nyberg L, Ohman A (2016) NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls. Mol Biosyst 12, 2562-2571.
19. Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D'Avanzo C, Chen H, Hooli B, Asselin C, Muffat J, Klee JB, Zhang C, Wainger BJ, Peitz M, Kovacs DM, Woolf CJ, Wagner SL, Tanzi RE, Kim DY (2014) A three-dimensional human neural cell culture model of Alzheimer's disease. Nature 515, 274-278.
20. Kim C-B, Choi YY, Song WK, Song K-B (2013) Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer's disease pathogenic factor. J Biomed Opt 19, 051205-051205.
21. Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M (2010) Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6, 78-95.
22. Dame ZT, Aziat F, Mandal R, Krishnamurthy R, Bouatra S, Borzouie S, Guo AC, Sajed T, Deng L, Lin H, Liu P, Dong E, Wishart DS (2015) The human saliva metabolome. Metabolomics 11, 1864-1883.
23. Ravanbakhsh S, Liu P, Bjordahl TC, Mandal R, Grant JR, Wilson M, Eisner R, Sinelnikov I, Hu X, Luchinat C, Greiner R, Wishart DS (2015) Accurate, fully-automated NMR spectral profiling for metabolomics. PLoS One 10, e0124219.
24. Xia J, Broadhurst DI, Wilson M, Wishart DS (2013) Translational biomarker discovery in clinical metabolomics: An introductory tutorial. Metabolomics 9, 280-299.